Increase/Decrease in Cash: The total change in cash for the company over the given period.
Oragenics, Inc. (OGEN) had Increase/Decrease in Cash of $10.54M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.07M |
|
-- |
|
-- |
|
$3.12M |
|
$-3.12M |
|
$0.06M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.12M |
|
$-3.12M |
|
1.56M |
|
1.56M |
|
$-1.96 |
|
$-1.96 |
|
| Balance Sheet Financials | |
$12.71M |
|
-- |
|
-- |
|
$12.71M |
|
$2.87M |
|
-- |
|
-- |
|
$2.87M |
|
$9.83M |
|
$9.83M |
|
$9.83M |
|
4.13M |
|
| Cash Flow Statement Financials | |
$-6.41M |
|
-- |
|
$16.95M |
|
$0.86M |
|
$11.40M |
|
|
Increase/Decrease in Cash |
$10.54M |
$-0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.19% |
|
-31.19% |
|
-24.14% |
|
-31.19% |
|
$2.38 |
|
$-4.11 |
|
$-4.11 |
|